Here are the numbers from the day of Insmed's Russell 3000 delisting last year.
About a minute before the close of normal trading for the day the Nasdaq site showed total shares traded of 232,257.
Transactions relating to the shares released by the tracker funds were subsequently registered - resulting in an additional 7,146,669 shares traded by the end of the evening.
My gut feeling at the time was that the tracker funds could not have been holding 28% of outstanding shares - rather that each share released by the funds was counted twice, the sale by the fund to the agent, followed by the sale by the agent to a waiting buyer.
But it's difficult to see how the tracker funds could not have been holding at least 3.5 million shares - corresponding to a free-float-adjusted market cap at the end of May the year 2011 of around $247.7 million.
If the closing price on May 31 this year is $8.50 Insmed's free-float-adjusted market cap will be around $255 million, and the tracker funds will need to buy back at least 3.5 million shares.
But this year there are only around 10 million shares in the hands of retail investors, very few of whom one suspects will be sufficiently naive to sell their shares for much less than their likely value after the Phase III results have been released.
The opportunity is obvious. All a big buyer monitoring the situation need do in order to bank a substantial profit in a few short weeks is to buy enough shares to drive the share price substantially higher by the end of May. A share price of $12 on May 31 would require the tracker funds to acquire over 5 million shares in June.
What investor would have any reason to sell lots of share at a price which gives away an unreasonable discount from the price at which he expects to be able to sell provided the Phase III results due mid-year reproduce the level of efficacy evidenced in the Phase II studies?
Who would bet against our new market valuation delivering a share price of at least $30?
getting to be very interesting times hhand - my guess on iplex is july 5th after our phase 2 arikace results. do you listen to all the conference calls? didn't sharoky mentioned something about announcing iplex on a friday - stock would be halted - and to let people absorb the information over a long weekend?
fuddy get on your knees and beg! this dog has no chance of seeing $30 but for your work tonight in the Taco shop parking lot you should make at least that!
10 bucks with approval 12 with NTM.what a blowhard\ if you know what I mean!
Need to repost what happened when it was added to Russel 4yrs ago. Think someone here had the price and corresponding dates. Also russell addition and deletion occur over a period of time that is they buy or sell over period not just one day. Just cross large blocks that day...Price they paid is weighted avg over that period....
Bear in mind that if we are to believe Rehdvm, evidence of substantial reduction of pseudomonas concentration in the lungs of an individual with Cystic Fibrosis would be strongly supportive of approval of Arikace for the treatment also of pneumonia such as Tuberculosis.